Experiments were performed to develop a design for a flow bioreactor. A system was constructed consisting of a small-scale bioreactor placed in a CO2 incubator, with four chambers for making tissue-engineered constructs, providing for long-term experiments in flow conditions maintaining sterility with different humidity and temperature factors in the culture and gaseous media. The adverse influences of flow on cell viability were minimized by optimizing the culture medium flow rate and the excess pressure in the flow chambers. The functional effectiveness of the bioreactor was demonstrated by chondrogenic differentiation of cells in a cell-engineered construct consisting of a microheterogeneous collagen-containing hydrogel matrix biopolymer, mesenchymal stromal cells from human fatty tissue, and chondrogenic differentiation medium as an example.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sart, S., Agathos, S. N., Li, Y., and Ma, T., “Regulation of mesenchymal stem cell 3D microenvironment: From macro to microfluidic bioreactors,” Biotechnol. J., 11, No. 1, 43-57 (2016).
Jin, G., Yang, G. H., and Kim, G., “Tissue engineering bioreactor systems for applying physical and electrical stimulations to cells,” J. Biomed. Mater. Res. B. Appl. Biomater., 103, No. 4, 935-948 (2015).
Massai, D., Cerino, G., Gallo, D., Pennella, F., Deriu, M. A., Rodriguez, A., Montevecchi, F. M., Bignardi, C., Audenino, A., and Morbiducci, U., “Bioreactors as engineering support to treat cardiac muscle and vascular disease,” J. Healthc. Eng., 4, No. 3, 329-370 (2013).
Schulz, R. M. and Bader, A., “Cartilage tissue engineering and bioreactor systems for the cultivation and stimulation of chondro-cytes,” Eur. Biophys. J., 36, No. 4-5, 539-568 (2007).
Guha Thakurta, S., Kraft, M., Viljoen, H. J., and Subramanian, A., “Enhanced depth-independent chondrocyte proliferation and phenotype maintenance in an ultrasound bioreactor and an assessment of ultrasound dampening in the scaffold,” Acta Biomater., 10, No. 11, 4798-4810 (2014).
State Standard GOST R ISO 10993.5-99 Medical Devices. Evaluation of the Biological Actions of Medical devices. Part 5. Toxicity Testing: In Vitro Methods (0993) [in Russian].
Egorova, V. A., Ponomareva, A. S., Bogdanova, N. B, et al., “Characteristic phenotype of mesenchymal stem cells from human fatty tissue by flow cytometry,” Tekhnol. Zhiv. Sistem, 6, No. 5, 40-46 (2009).
Sevastianov, V. I., “Biomaterials, drug delivery systems, and bio-engineering,” Vestn. Transplantol. Iskusstv. Org., XI, No. 3, 69-80 (2009).
Sevastianov, V. I. and Perova, N. V., “Biopolymeric heterogeneous hydrogel Sfero®GEL’ – a biodegradable implant for injection for replacement and regenerative medicine,” Praktichesk. Med., 84, No. 8, 120-126 (2014).
Sevastianov, V. I, “Tissue engineering technologies and regenerative medicine,” Vestn. Transplantol. Iskusstv. Org., 16, No. 3, 93-108 (2014).
Heiner, A. D. and Martin, J. A., “Cartilage responses to a novel traxial mechanostimulatory culture system,” J. Biomech., 37, 689-695 (2004).
Baumgartner, W., Welti, M., Hild, N., Hess, S. C., Stark, W. J., Bürgisser, G. M., Giovanoli, P., and Buschmann, J., “Tissue mechanics of piled critical size biomimetic and biominerizable nanocomposites: Formation of bioreactor-induced stem cell gradients under perfusion and compression,” J. Mech. Behav. Biomed. Mater., 47, 124-134 (2015).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Meditsinskaya Tekhnika, Vol. 51, No. 3, May-Jun., 2017, pp. 9-11.
Rights and permissions
About this article
Cite this article
Sevastianov, V.I., Basok, Y.B., Grigoryev, A.M. et al. A Perfusion Bioreactor for Making Tissue-Engineered Constructs. Biomed Eng 51, 162–165 (2017). https://doi.org/10.1007/s10527-017-9706-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10527-017-9706-7